advertisement
Abstract #47090 Published in IGR 13-3
Glaucoma costs in Denmark in treatment naive patients
Olsen J; Berdeaux G; Skov JActa Ophthalmologica 2011;
Purpose: To describe the costs and providers of glaucoma treatment in Denmark. Methods: Analyses were based on National Register data. Glaucoma/OHT patients were identified by their first prescription for glaucoma medication (ATC-codes) in the Danish Register of Medicinal Product Statistics 2002-2007. Patients had used no glaucoma medication for 6months. Data for 2007 were sampled cross-sectionally for a budgetary analysis of glaucoma (ICD10 code) medication and services consumed in the primary and secondary health care services. Patients were categorized according to their number of treatment changes. Results: The Danish annual incidence rate of glaucoma was estimated at 1.2 per 1000 adult persons. Thirty-seven per cent of patients (men 44%, mean age 68years; women 56%, mean age 71years) persisted with their initial treatment regimen, 21% had changed to a second regimen, and 43% had experienced (greater-than or equal to)3 regimens. Treatment costs increased with the number of sequential regimens. Annual glaucoma costs (health care sector perspective) were (euro)305 for patients under their initial regimen, increasing to (euro)740 with (greater-than or equal to)3 regimens. Drug costs accounted for 57% of total cost. Conclusions: Drugs represented the major cost of glaucoma, and those costs increased, obviously, with the number of treatment changes.
G. Berdeaux. Alcon France, 4, rue Henri Sainte-Claire Deville, F-92563 Rueil-Malmaison, France, .
Classification:
14 Costing studies; pharmacoeconomics
